多囊卵巢
肠道菌群
丁酸盐
淀粉
内分泌学
丙酸盐
生物
内科学
酪氨酸
生物化学
发酵
胰岛素
医学
胰岛素抵抗
作者
Yufeng He,Liuting Shi,Yajin Qi,Li Wang,Jianxin Zhao,Hao Zhang,Gang Wang,Wei Chen
标识
DOI:10.1016/j.carbpol.2022.119304
摘要
Polycystic ovary syndrome (PCOS) is an endocrine disorder that affects women of reproductive age. Resistant starch can be fermented by gut microbes then produce short-chain fatty acids (SCFAs). It was reported SCFAs might play a key role in gut microbiota-dependent therapy of PCOS. However, the effects of resistant starch on PCOS symptoms have not yet been investigated. Here, maize starch was acylated with specific SCFAs. Our results indicated that acylated starch can release acetate, propionate, and butyrate into the caecum and colon. Treatment with butylated starch (BS) alleviated abnormal ovarian morphology, metabolic disorders, and sex hormone imbalance in letrozole-treated rats, whereas treatment with acetylated starch and propylated starch did not exhibit such effects. Furthermore, BS stimulated the secretion of peptide tyrosine-tyrosine into the serum by activating a G protein-coupled receptor, GPR41, which further affected disease phenotypes. In addition, compared with caecal microbiota, faecal microbiota was more affected by BS. Butyrate-producing microbes were enriched in faeces after BS treatment and may have helped further to relieve PCOS symptoms.
科研通智能强力驱动
Strongly Powered by AbleSci AI